PARANEOPLASTIC DERMATOMYOSITIS

This adverse event was reported 93 times

These drugs are most commonly taken by patients reporting PARANEOPLASTIC DERMATOMYOSITIS:

# Drug Count
0 DOCETAXEL 15
1 DOCETAXEL ANHYDROUS 15
2 PEMBROLIZUMAB 15
3 CARBOPLATIN 14
4 BEVACIZUMAB 10
5 OXALIPLATIN 10
6 ACETAMINOPHEN 9
7 ACETAMINOPHEN 500MG 9
8 ACETAMINOPHEN TABLET EXTENDED RELEASE 9
9 DEXAMETHASONE 9
See all common drugs associated with PARANEOPLASTIC DERMATOMYOSITIS

PARANEOPLASTIC DERMATOMYOSITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 2 0.0009
1 PEGFILGRASTIM 8 0.0007
2 TRASTUZUMAB-ANNS 1 0.0007
3 INSTALAX POLYETHYLENE GLYCOL 3350 4 0.0003
4 POLYETHYLENE GLYCOL 400 4 0.0003
5 BICALUTAMIDE 4 0.0003
6 ENFORTUMAB VEDOTIN 2 0.0003
7 CHLORTHALIDONE 3 0.0003
8 AVELUMAB 1 0.0002
9 DOCETAXEL 15 0.0002
See all drugs enriched for association with PARANEOPLASTIC DERMATOMYOSITIS